array(40) {
  [0]=>
  string(4) "4859"
  ["article_id"]=>
  string(4) "4859"
  [1]=>
  string(79) "4thInternational Conference on Tumor & Cancer Immunology and Pediatric-oncology"
  ["article_title"]=>
  string(79) "4thInternational Conference on Tumor & Cancer Immunology and Pediatric-oncology"
  [2]=>
  string(150) "Conferenceseries takes the privilege to welcome participants across the globe to the International Conference on Tumor & Cancer Immunology and"
  ["short_description"]=>
  string(150) "Conferenceseries takes the privilege to welcome participants across the globe to the International Conference on Tumor & Cancer Immunology and"
  [3]=>
  string(515) "Conferenceseries takes the privilege to welcome participants across the globe to the International Conference on Tumor & Cancer Immunology and Pediatric-oncology which is slated for October 23-24, 2019 inAmsterdam, Netherlands.&#nlThis interdisciplinary conference is the premier gathering of people working in the field of tumor Immunology and cancer Immunology,Paediatric-oncology as well as the immunotherapy researchers. The 'Tumor Immunology 2019' program will showcase new scientific knowle..."
  ["description"]=>
  string(515) "Conferenceseries takes the privilege to welcome participants across the globe to the International Conference on Tumor & Cancer Immunology and Pediatric-oncology which is slated for October 23-24, 2019 inAmsterdam, Netherlands.&#nlThis interdisciplinary conference is the premier gathering of people working in the field of tumor Immunology and cancer Immunology,Paediatric-oncology as well as the immunotherapy researchers. The 'Tumor Immunology 2019' program will showcase new scientific knowle..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(109) "https://www.pharmiweb.com/event/4thinternational-conference-on-tumor-cancer-immunology-and-pediatric-oncology"
  ["blog_url"]=>
  string(109) "https://www.pharmiweb.com/event/4thinternational-conference-on-tumor-cancer-immunology-and-pediatric-oncology"
  [15]=>
  string(19) "2019-03-15 18:13:04"
  ["add_date"]=>
  string(19) "2019-03-15 18:13:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-27 14:12:08"
  ["create_at"]=>
  string(19) "2019-09-27 14:12:08"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2134"
  ["article_id"]=>
  string(4) "2134"
  [1]=>
  string(65) "WI Watchlist: Foxconn Fund, UW Accelerator, MSOE A.I. Hall & More"
  ["article_title"]=>
  string(65) "WI Watchlist: Foxconn Fund, UW Accelerator, MSOE A.I. Hall & More"
  [2]=>
  string(150) "It’s time to catch up on Wisconsin innovation news: —Jason Franklin will manage the Wisconn Valley Venture Fund, a $100 million fund forme"
  ["short_description"]=>
  string(150) "It’s time to catch up on Wisconsin innovation news: —Jason Franklin will manage the Wisconn Valley Venture Fund, a $100 million fund forme"
  [3]=>
  string(409) "It’s time to catch up on Wisconsin innovation news: —Jason Franklin will manage the Wisconn Valley Venture Fund, a $100 million fund formed last August by Foxconn Technology Group and three leading Wisconsin businesses and organizations: Advocate Aurora Health, Northwestern Mutual, and Johnson Controls (NYSE: JCI). Foxconn, a Taiwanese manufacturing giant, has said it’s building […]"
  ["description"]=>
  string(409) "It’s time to catch up on Wisconsin innovation news: —Jason Franklin will manage the Wisconn Valley Venture Fund, a $100 million fund formed last August by Foxconn Technology Group and three leading Wisconsin businesses and organizations: Advocate Aurora Health, Northwestern Mutual, and Johnson Controls (NYSE: JCI). Foxconn, a Taiwanese manufacturing giant, has said it’s building […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "37"
  ["rss_id"]=>
  string(2) "37"
  [14]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Egf7AR_TXWc/"
  ["blog_url"]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Egf7AR_TXWc/"
  [15]=>
  string(19) "2019-03-15 13:01:48"
  ["add_date"]=>
  string(19) "2019-03-15 13:01:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5248"
  ["article_id"]=>
  string(4) "5248"
  [1]=>
  string(64) "An Introduction to the Design and Development of Medical Devices"
  ["article_title"]=>
  string(64) "An Introduction to the Design and Development of Medical Devices"
  [2]=>
  string(3) "TBC"
  ["short_description"]=>
  string(3) "TBC"
  [3]=>
  string(3) "TBC"
  ["description"]=>
  string(3) "TBC"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(96) "https://www.pharmiweb.com/event/an-introduction-to-the-design-and-development-of-medical-devices"
  ["blog_url"]=>
  string(96) "https://www.pharmiweb.com/event/an-introduction-to-the-design-and-development-of-medical-devices"
  [15]=>
  string(19) "2019-03-15 10:22:21"
  ["add_date"]=>
  string(19) "2019-03-15 10:22:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:27"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5330"
  ["article_id"]=>
  string(4) "5330"
  [1]=>
  string(58) "Economic Modelling Techniques for the NHS & Public Health "
  ["article_title"]=>
  string(58) "Economic Modelling Techniques for the NHS & Public Health "
  [2]=>
  string(150) "As the demand for health and care services grows and finances become more constrained, there is an increasing need for economic evaluation in the publ"
  ["short_description"]=>
  string(150) "As the demand for health and care services grows and finances become more constrained, there is an increasing need for economic evaluation in the publ"
  [3]=>
  string(502) "As the demand for health and care services grows and finances become more constrained, there is an increasing need for economic evaluation in the public sector. NHS, social care and public health organisations are expected to be able to economically justify any changes in care pathways they propose and there are concerns not only around cost-effectiveness but also the affordability of new initiatives.&#nlMany public sector bodies are under pressure to achieve efficiency and productivity savings..."
  ["description"]=>
  string(502) "As the demand for health and care services grows and finances become more constrained, there is an increasing need for economic evaluation in the public sector. NHS, social care and public health organisations are expected to be able to economically justify any changes in care pathways they propose and there are concerns not only around cost-effectiveness but also the affordability of new initiatives.&#nlMany public sector bodies are under pressure to achieve efficiency and productivity savings..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(87) "https://www.pharmiweb.com/event/economic-modelling-techniques-for-the-nhs-public-health"
  ["blog_url"]=>
  string(87) "https://www.pharmiweb.com/event/economic-modelling-techniques-for-the-nhs-public-health"
  [15]=>
  string(19) "2019-03-14 20:27:21"
  ["add_date"]=>
  string(19) "2019-03-14 20:27:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4520"
  ["article_id"]=>
  string(4) "4520"
  [1]=>
  string(50) "Software to Support the Systematic Review Process "
  ["article_title"]=>
  string(50) "Software to Support the Systematic Review Process "
  [2]=>
  string(150) "Systematic reviews can be time consuming, logistically challenging and labour intensive. These and other challenges have led to the development of var"
  ["short_description"]=>
  string(150) "Systematic reviews can be time consuming, logistically challenging and labour intensive. These and other challenges have led to the development of var"
  [3]=>
  string(500) "Systematic reviews can be time consuming, logistically challenging and labour intensive. These and other challenges have led to the development of various special-purpose software tools to support the systematic review production process. Such tools extend beyond the scope of more established general-purpose systems (e.g. reference managers, word processors and spreadsheet packages), which are already in wide use and, instead, aim to provide tailored support for particular review activities o..."
  ["description"]=>
  string(500) "Systematic reviews can be time consuming, logistically challenging and labour intensive. These and other challenges have led to the development of various special-purpose software tools to support the systematic review production process. Such tools extend beyond the scope of more established general-purpose systems (e.g. reference managers, word processors and spreadsheet packages), which are already in wide use and, instead, aim to provide tailored support for particular review activities o..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(81) "https://www.pharmiweb.com/event/software-to-support-the-systematic-review-process"
  ["blog_url"]=>
  string(81) "https://www.pharmiweb.com/event/software-to-support-the-systematic-review-process"
  [15]=>
  string(19) "2019-03-14 20:25:52"
  ["add_date"]=>
  string(19) "2019-03-14 20:25:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4534"
  ["article_id"]=>
  string(4) "4534"
  [1]=>
  string(69) "Advanced Search Techniques for Systematic Reviews, HTA and Guidelines"
  ["article_title"]=>
  string(69) "Advanced Search Techniques for Systematic Reviews, HTA and Guidelines"
  [2]=>
  string(150) "Extensive literature searches are the foundation of high quality systematic reviews, health technology assessment (HTA), guideline development and oth"
  ["short_description"]=>
  string(150) "Extensive literature searches are the foundation of high quality systematic reviews, health technology assessment (HTA), guideline development and oth"
  [3]=>
  string(500) "Extensive literature searches are the foundation of high quality systematic reviews, health technology assessment (HTA), guideline development and other major projects. Conducting searches to retrieve research evidence from databases and other resources requires a range of knowledge and skills. There are constant challenges to keeping up-to-date with new database features and approaches to achieving efficient searches. Search approaches may need to be adapted depending on the end-product whic..."
  ["description"]=>
  string(500) "Extensive literature searches are the foundation of high quality systematic reviews, health technology assessment (HTA), guideline development and other major projects. Conducting searches to retrieve research evidence from databases and other resources requires a range of knowledge and skills. There are constant challenges to keeping up-to-date with new database features and approaches to achieving efficient searches. Search approaches may need to be adapted depending on the end-product whic..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(102) "https://www.pharmiweb.com/event/advanced-search-techniques-for-systematic-reviews-hta-and-guidelines-1"
  ["blog_url"]=>
  string(102) "https://www.pharmiweb.com/event/advanced-search-techniques-for-systematic-reviews-hta-and-guidelines-1"
  [15]=>
  string(19) "2019-03-14 20:22:51"
  ["add_date"]=>
  string(19) "2019-03-14 20:22:51"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4566"
  ["article_id"]=>
  string(4) "4566"
  [1]=>
  string(53) "Understanding and Critiquing Health Economics Models "
  ["article_title"]=>
  string(53) "Understanding and Critiquing Health Economics Models "
  [2]=>
  string(150) "This training day aims to provide the participant with a sufficient grounding to effectively critique and validate models. The training day will be pa"
  ["short_description"]=>
  string(150) "This training day aims to provide the participant with a sufficient grounding to effectively critique and validate models. The training day will be pa"
  [3]=>
  string(499) "This training day aims to provide the participant with a sufficient grounding to effectively critique and validate models. The training day will be particularly useful to those people who commission health economic models, or use models to help make decisions. As well as discussing the strengths and uses of economic modelling, the training day will also explore the limitations and constraints of different approaches and will explore a number of commonly-observed errors in models. Please note..."
  ["description"]=>
  string(499) "This training day aims to provide the participant with a sufficient grounding to effectively critique and validate models. The training day will be particularly useful to those people who commission health economic models, or use models to help make decisions. As well as discussing the strengths and uses of economic modelling, the training day will also explore the limitations and constraints of different approaches and will explore a number of commonly-observed errors in models. Please note..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(84) "https://www.pharmiweb.com/event/understanding-and-critiquing-health-economics-models"
  ["blog_url"]=>
  string(84) "https://www.pharmiweb.com/event/understanding-and-critiquing-health-economics-models"
  [15]=>
  string(19) "2019-03-14 20:19:17"
  ["add_date"]=>
  string(19) "2019-03-14 20:19:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:22"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1804"
  ["article_id"]=>
  string(4) "1804"
  [1]=>
  string(94) "Emerald acquires Mind Tools and strengthens its position as a leading global learning business"
  ["article_title"]=>
  string(94) "Emerald acquires Mind Tools and strengthens its position as a leading global learning business"
  [2]=>
  string(150) "Bingley, United Kingdom, 14 March 2019 – Emerald Group, the global provider of research and learning resources, today announces the successful a"
  ["short_description"]=>
  string(150) "Bingley, United Kingdom, 14 March 2019 – Emerald Group, the global provider of research and learning resources, today announces the successful a"
  [3]=>
  string(534) "Bingley, United Kingdom, 14 March 2019 – Emerald Group, the global provider of research and learning resources, today announces the successful acquisition of Mind Tools, the digital learning and performance support company. Emerald is uniquely placed amongst its competitors, with a strong position in both the academic research market and learning and performance development in the corporate and public space. The Group’s shared ambition is to unlock the talent and potential in people to help...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(534) "Bingley, United Kingdom, 14 March 2019 – Emerald Group, the global provider of research and learning resources, today announces the successful acquisition of Mind Tools, the digital learning and performance support company. Emerald is uniquely placed amongst its competitors, with a strong position in both the academic research market and learning and performance development in the corporate and public space. The Group’s shared ambition is to unlock the talent and potential in people to help...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "4"
  ["category"]=>
  string(1) "4"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "65"
  ["rss_id"]=>
  string(2) "65"
  [14]=>
  string(89) "http://www.realwire.com/releases/Emerald-acquires-Mind-Tools-and-strengthens-its-position"
  ["blog_url"]=>
  string(89) "http://www.realwire.com/releases/Emerald-acquires-Mind-Tools-and-strengthens-its-position"
  [15]=>
  string(19) "2019-03-14 20:12:00"
  ["add_date"]=>
  string(19) "2019-03-14 20:12:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-01 11:23:47"
  ["create_at"]=>
  string(19) "2019-04-01 11:23:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5276"
  ["article_id"]=>
  string(4) "5276"
  [1]=>
  string(58) "Development of Combination Products: Critical Interactions"
  ["article_title"]=>
  string(58) "Development of Combination Products: Critical Interactions"
  [2]=>
  string(137) "Linking the technical requirements of device design and pharmaceutical product development.Using QbD to deliver drug/device combinations."
  ["short_description"]=>
  string(137) "Linking the technical requirements of device design and pharmaceutical product development.Using QbD to deliver drug/device combinations."
  [3]=>
  string(137) "Linking the technical requirements of device design and pharmaceutical product development.Using QbD to deliver drug/device combinations."
  ["description"]=>
  string(137) "Linking the technical requirements of device design and pharmaceutical product development.Using QbD to deliver drug/device combinations."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(89) "https://www.pharmiweb.com/event/development-of-combination-products-critical-interactions"
  ["blog_url"]=>
  string(89) "https://www.pharmiweb.com/event/development-of-combination-products-critical-interactions"
  [15]=>
  string(19) "2019-03-14 13:08:54"
  ["add_date"]=>
  string(19) "2019-03-14 13:08:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5289"
  ["article_id"]=>
  string(4) "5289"
  [1]=>
  string(44) "Leading & Developing Successful Pharma Teams"
  ["article_title"]=>
  string(44) "Leading & Developing Successful Pharma Teams"
  [2]=>
  string(98) "Creating a team that speaks and acts with one vision in the pharma/device/animal health industries"
  ["short_description"]=>
  string(98) "Creating a team that speaks and acts with one vision in the pharma/device/animal health industries"
  [3]=>
  string(98) "Creating a team that speaks and acts with one vision in the pharma/device/animal health industries"
  ["description"]=>
  string(98) "Creating a team that speaks and acts with one vision in the pharma/device/animal health industries"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(74) "https://www.pharmiweb.com/event/leading-developing-successful-pharma-teams"
  ["blog_url"]=>
  string(74) "https://www.pharmiweb.com/event/leading-developing-successful-pharma-teams"
  [15]=>
  string(19) "2019-03-14 13:04:47"
  ["add_date"]=>
  string(19) "2019-03-14 13:04:47"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2014"
  ["article_id"]=>
  string(4) "2014"
  [1]=>
  string(94) "Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial Of Troriluzole"
  ["article_title"]=>
  string(94) "Biohaven Enrolls First Patient In Phase 3 Spinocerebellar Ataxia Clinical Trial Of Troriluzole"
  [2]=>
  string(150) "NEW HAVEN, Conn., March 14, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company"
  ["short_description"]=>
  string(150) "NEW HAVEN, Conn., March 14, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company"
  [3]=>
  string(242) "NEW HAVEN, Conn., March 14, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and..."
  ["description"]=>
  string(242) "NEW HAVEN, Conn., March 14, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(275) "https://www.drugs.com/clinical_trials/biohaven-enrolls-first-patient-phase-3-spinocerebellar-ataxia-clinical-trial-troriluzole-18099.html?utm_source=ddc&utm_medium=rss&utm_campaign=Biohaven+Enrolls+First+Patient+In+Phase+3+Spinocerebellar+Ataxia+Clinical+Trial+Of+Troriluzole"
  ["blog_url"]=>
  string(275) "https://www.drugs.com/clinical_trials/biohaven-enrolls-first-patient-phase-3-spinocerebellar-ataxia-clinical-trial-troriluzole-18099.html?utm_source=ddc&utm_medium=rss&utm_campaign=Biohaven+Enrolls+First+Patient+In+Phase+3+Spinocerebellar+Ataxia+Clinical+Trial+Of+Troriluzole"
  [15]=>
  string(19) "2019-03-14 12:03:43"
  ["add_date"]=>
  string(19) "2019-03-14 12:03:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1942"
  ["article_id"]=>
  string(4) "1942"
  [1]=>
  string(65) "Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA"
  ["article_title"]=>
  string(65) "Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA"
  [2]=>
  string(150) "SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments f"
  ["short_description"]=>
  string(150) "SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments f"
  [3]=>
  string(250) "SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted its response to the U.S...."
  ["description"]=>
  string(250) "SOLANA BEACH, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted its response to the U.S...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(153) "https://www.drugs.com/nda/gimoti_190314.html?utm_source=ddc&utm_medium=rss&utm_campaign=Evoke+Pharma+Submits+Response+to+FDA+Review+Letter+for+Gimoti+NDA"
  ["blog_url"]=>
  string(153) "https://www.drugs.com/nda/gimoti_190314.html?utm_source=ddc&utm_medium=rss&utm_campaign=Evoke+Pharma+Submits+Response+to+FDA+Review+Letter+for+Gimoti+NDA"
  [15]=>
  string(19) "2019-03-14 12:03:27"
  ["add_date"]=>
  string(19) "2019-03-14 12:03:27"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:51"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}